Why the study?
Does low serum albumin predict major adverse cardiac events in patients with advanced atherosclerosis and severe peripheral artery disease?
Does low serum albumin predict major adverse cardiac events in patients with advanced atherosclerosis and severe peripheral artery disease?
Low serum albumin is an independent predictor of MACE in patients with advanced atherosclerosis and severe peripheral artery disease, particularly useful for risk stratification in those with fewer traditional cardiovascular risk factors.
No takes yet. Share an insight, caveat, or question.
May refine MACE risk stratification in severe PAD with few traditional factors; hypothesis-generating and requires prospective validation before practice change.
Exner et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: